<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Pain Med</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Pain Med</journal-id><journal-id journal-id-type="doi">10.5812/aapm</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Anesthesiology and Pain Medicine</journal-title></journal-title-group><issn pub-type="ppub">2228-7523</issn><issn pub-type="epub">2228-7531</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24701419</article-id><article-id pub-id-type="pmc">3961031</article-id><article-id pub-id-type="doi">10.5812/aapm.14129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effect of Intravenous Patient Controlled Ketamine Analgesiaon Postoperative Pain in Opium Abusers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dahi-Taleghani</surname><given-names>Mastane</given-names></name><xref ref-type="aff" rid="aff30457">1</xref></contrib><contrib contrib-type="author"><name><surname>Fazli</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff30457">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghasemi</surname><given-names>Mahshid</given-names></name><xref ref-type="aff" rid="aff30457">1</xref></contrib><contrib contrib-type="author"><name><surname>Vosoughian</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="aff30457">1</xref></contrib><contrib contrib-type="author"><name><surname>Dabbagh</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff30457">1</xref><xref ref-type="corresp" rid="cor30458">*</xref></contrib></contrib-group><aff id="aff30457"><label>1</label>Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="cor30458"><label>*</label>Corresponding author: Ali Dabbagh, Anesthesiology Research Center, ShahidBeheshti University of Medical Sciences, Tehran, Iran. Tel: +98-989121972368, Fax: +98-982122432572, E-mail: <email>alidabbagh@yahoo.com</email>, <email>alidabbagh@sbmu.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>2</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2014</year></pub-date><volume>4</volume><issue>1</issue><elocation-id>e14129</elocation-id><history><date date-type="received"><day>10</day><month>8</month><year>2013</year></date><date date-type="rev-recd"><day>22</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>01</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM)</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Acutepostoperative pain is among the worst experience that patient scan undergo, and many analgesics have been used to suppress it; especially in chronic opium abusers. Ketamine is an N-methyl-D-aspartate antagonist analgesic, having both anesthetic and analgesic properties, which are not affected to the same extent in chronic opium abusers.</p></sec><sec><title>Objectives:</title><p>In this study, we assessed the analgesic effects of ketamine added to morphine as a patient-controlled analgesia method for acute pain management, compared with a placebo, inchronic maleopium abusers.</p></sec><sec><title>Patients and Methods:</title><p>After institutional review board approval for ethical considerations, a randomized double-blinded placebo controlled clinical trial was conducted. A total of 140 male patients aged 18-65 years, undergoing orthopedic surgery, were entered into the study after matching inclusion and exclusion criteria. All patients received the same anesthesia method; while the first group received ketamine (1mg/mL) and morphine (0.5 mg/mL) as a patient-controlled analgesia (70 patients), the second group received morphine (0.5 mg/mL) plus normal saline (70 patients). P value less than 0.05 was considered statistically significant.</p></sec><sec><title>Results:</title><p>The ketamine and morphine group of patients experienced less postoperative pain and required less postoperative rescue analgesia. However, the unwanted postoperative side effects were nearly the same; although increased levels of postoperative nausea and vomiting were observed in the ketamine and morphine group</p></sec><sec><title>Conclusions:</title><p>This study demonstrated improved analgesic effects after using intravenous patient controlled analgesia with ketamine on postoperative pain in opium abusers.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Ketamine</kwd><kwd>Acute Pain</kwd><kwd>Opium</kwd><kwd>Drug Users</kwd></kwd-group></article-meta></front><body><sec id="sec44000"><title>1. Background</title><p>Acute postoperative pain is one of the most difficult experiences that patients must tolerate. Many different analgesics have been used; each having their own special drawbacks (<xref rid="A14129R1" ref-type="bibr">1</xref>). Among patients with acute pain, chronic opium abusers are a real challenge (<xref rid="A14129R2" ref-type="bibr">2</xref>-<xref rid="A14129R5" ref-type="bibr">5</xref>), as they usually need extremely high doses of analgesics for acute pain suppression, and in addition, some analgesics are not very effective on them (<xref rid="A14129R6" ref-type="bibr">6</xref>, <xref rid="A14129R7" ref-type="bibr">7</xref>). To resolve this problem, many analgesics have been tested with controversial results.</p><p>Ketamine is an N-methyl-D-aspartate antagonist (<xref rid="A14129R8" ref-type="bibr">8</xref>-<xref rid="A14129R10" ref-type="bibr">10</xref>), and it is mainly used as an anesthetic with simultaneous analgesic properties. Since it is an NMDA antagonist and its analgesic properties do not stimulate opioid receptors, it induces analgesia through NMDA receptors instead, which is a more effective mechanism in opium abusers (<xref rid="A14129R10" ref-type="bibr">10</xref>-<xref rid="A14129R18" ref-type="bibr">18</xref>). Although there are some controversies regarding ketamine (<xref rid="A14129R19" ref-type="bibr">19</xref>-<xref rid="A14129R22" ref-type="bibr">22</xref>), recent clinical studies have demonstrated its effectiveness as an analgesic agent in opium abusers (11). However, the analgesic effects of ketamine in improving clinical outcomes in opium abusers, especially when used as a patient controlled analgesia (PCA), are not well defined and need more research (<xref rid="A14129R23" ref-type="bibr">23</xref>).</p></sec><sec id="sec44001"><title>2. Objectives</title><p>In this study, we assessed the analgesic effects of ketamine when added to a morphine sulfate solution as a PCA method for acute pain management, compared with a placebo in male patients with a history of chronic opium abuse.</p></sec><sec id="sec44004"><title>3. Patients and Methods</title><p>This was a randomized double-blinded placebo controlled clinical trial. The proposal of the study was approved for ethical considerations by the institutional review board of Shahid Beheshti University of Medical Sciences, Tehran, Iran. Furthermore, the manuscript was approved by the Ethics Committee, Research Deputy, Shahid Beheshti University of Medical Sciences and the following comments were followed throughout all stages of the study:</p><p>1) The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.</p><p>2) Informed written consent was taken from each patient separately, before entering the study</p><sec id="sec44002"><title>3.1. Patient Selection and Sample Size Calculation</title><p>All male patients, aged 18-65 years undergoing orthopedic surgery in a university hospital, were considered as the target population. After considering the inclusion and exclusion criteria and calculating the sample size, the patients entering the study were selected. The inclusion criteria consisted of; male gender, elective orthopedic surgery of the lower limb, history of opium abuse (inhalational or oral routes, on a regular basis for at least two years, leading to drug craving behaviors in case of drug deprivation, all based on the patient's declaration), application of general anesthesia, no contraindication for general anesthesia, and having no significant co-morbid disease (i.e. all were American Society of Anesthesiology (ASA) class I or II patients). The exclusion criteria included; female gender, other anesthetic methods (except for general anesthesia), ASA class more than III, duration of anesthesia less than one hour, other routes of drug abuse (except for inhalational opium for two years), and patient's refusal to continue the study after primary approval for study entry. The patients were then randomly assigned to one of the two study groups based on a computer table of random numbers:</p><p>1) The first group consisted of 70 patients who received ketamine plus morphine (KM group) as a PCA method. In this group, a combined solution of 1 mg/mL ketamine and 0.5 mg/mL morphine was prepared as the PCA analgesia protocol. This was started immediately in the postoperative period, at 10 minutes intervals, and each bolus contained 2 mL of the solution (i.e. 2 mg ketamine plus 1 mg morphine).</p><p>2) The second group also consisted of 70 patients, and they received a combination of morphine (0.5 mg/mL) plus normal saline solution (M group). Again, PCA analgesia was started immediately in the postoperative period at 10 minutes intervals, using 2 mL of the solution in each PCA bolus (i.e. 1 mg morphine in each bolus). A brief presentation of these stages is demonstrated in <xref ref-type="fig" rid="fig9199">Figure 1</xref>. </p><p>Sample size determination was done after a power analysis (power = 0.8; &#x003b2; = 0.2; &#x003b1; = 0.02) using sample size software (PASS 2005, NCSS LLC, Kaysville, Utah, USA). The observed frequency for acute postoperative pain in similar patients requesting analgesics was also considered as the clinical criterion for determination of the sample size, and based on the following data and sample size equation (<xref rid="A14129R24" ref-type="bibr">24</xref>-<xref rid="A14129R27" ref-type="bibr">27</xref>):</p><p><inline-formula>n = 2[(Z<sub>&#x003b2;</sub>+Z<sub>&#x003b1;</sub>) &#x003c3; /&#x00394;]<sup>2</sup></inline-formula></p><p>Where:</p><list list-type="bullet"><list-item><p><inline-formula>n (sample size in each group) = 62</inline-formula></p></list-item><list-item><p><inline-formula>&#x003b1; = 0.05</inline-formula></p></list-item><list-item><p><inline-formula>Z&#x003b1; = 1.96</inline-formula></p></list-item><list-item><p><inline-formula>&#x003b2; = 0.2</inline-formula></p></list-item><list-item><p><inline-formula>Z&#x003b2; = 0.84</inline-formula></p></list-item><list-item><p><inline-formula>&#x003c3; (estimated standard deviation based on similar studies) = 2</inline-formula></p></list-item><list-item><p><inline-formula>&#x00394; = the estimated effect size (i.e. the minimal difference desired between the two study interventions or the clinical outcomes of the two groups)</inline-formula></p></list-item></list><p>Considering a possible 10% dropout, 70 patients were considered as the sample size for each study arm, and consequently total number of 140 patients were selected and entered the study after matching the inclusion and exclusion criteria as follows.</p></sec><sec id="sec44003"><title>3.2. Clinical Management of Patients</title><p>All patients were visited the night before surgery and the study protocol was described to them. This visit was the task of the authors &#x02018;colleague. He explained the process of the study and took informed written consents for entering the study during this visit. He also explained that entering the study was a completely voluntary issue and any patient entering the study could exit the research process at any time during the study period. In addition, acceptance or refusal to enter the study, or refusal to continue, had no effect on the treatment process (including the treatment of acute pain).</p><p>The patients underwent general anesthesia for elective lower limb orthopedic surgery. After entering the operating theatre their vital signs were monitored using; electrocardiogram, pulse oximeter, end tidal CO<sub>2</sub>, and noninvasive blood pressure. For each patient, two intravenous lines were inserted for the administration of fluids, blood and drugs, all according to the study's protocol and the patient's needs. Anesthesia was induced using 0.2 mg/Kg IV midazolam, 200 &#x003bc;g fentanyl, 5 mg/Kg sodium thiopental, and 5 mg/Kg atracurium. Before anesthesia induction, 10 ml/Kg of Ringer's solution was administered freely to compensate for NPO time deficit. For maintenance of the anesthesia, 0.6-1% isoflurane was used to keep the anesthesia depth between 40-60, using Bispectral Index (BIS) monitoring. During final skin suturing, isoflurane was discontinued, and the patients were reversed pharmacologically, using 0.05 mg/kg neostigmine plus 0.02 mg/Kg atropine. After full muscle force recovery and an appropriate level of consciousness, the patients were extubated. Ketamine was not used for anesthesia induction or maintenance at any time during the study. The patients were transferred to the postanaesthetic care unit (PACU) for hemodynamic control, and regaining a full level of consciousness before starting acute pain control remedies.</p><p>During the postoperative period, the patients' postoperative pain scores were controlled using a visual analog scale (VAS), and their respiratory status; using pulse oximetry and respiratory rates, were measured. Postoperative pain was documented and registered at 1, 6 and 24 hours after the operation. In addition the patients received supplementary nasal oxygen, if they had any decline of oxygen saturation (SpO<sub>2</sub>) below 92%. However, postoperative pain scores greater than 3 out of 10, mandated postoperative pain control using analgesics through the following protocol:</p><list list-type="order"><list-item><p> Starting PCA as defined in the patient groupings (KM group vs. M group).</p></list-item><list-item><p> Respiratory monitoring including pulse oximetry.</p></list-item><list-item><p> Adding supplementary nasal oxygen if SpO<sub>2</sub> was less than 92%.</p></list-item><list-item><p> Administration of supplementary intravenous morphine to each of the patients having a VAS score more than 3 out of 10 in the postoperative period, regardless of their study group.</p></list-item><list-item><p> Calculating the extra morphine doses in each patient during the first 24 hour period after the operation.</p></list-item><list-item><p> Assessment of postoperative nausea and vomiting frequencies in each patient in the first 24 hour period after the operation.</p></list-item></list><p>Data were collected and analyzed using SPSS software, (version 16). A Student's t-test was used for data analysis. P value less than 0.05 were considered statistically significant.</p><fig id="fig9199" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Summary of the Study Stages are Presented in the Diagram</title></caption><graphic xlink:href="aapm-04-01-14129-i001"/></fig></sec></sec><sec id="sec44005"><title>4. Results</title><p>The two study groups had no significant difference regarding baseline demographic data (<xref ref-type="table" rid="tbl11608">Table 1</xref>). While the results of postoperative pain scores were lower in the KM group, they also experienced less postoperative pain, and needed less postoperative rescue analgesia (<xref ref-type="table" rid="tbl11609">Tables 2</xref> and <xref ref-type="table" rid="tbl11611">3</xref>) These results suggest a greater analgesic effect of the PCA solution used in the KM patient group. However, the unwanted postoperative side effects were very similar; although increased postoperative nausea and vomiting was observed in the KM group (<xref ref-type="table" rid="tbl11610">Table 4</xref>). </p><table-wrap id="tbl11608" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Baseline Demographic Data in the Two Study Groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th style="text-align: left;" rowspan="1" colspan="1">KM Group <sup><xref ref-type="table-fn" rid="fn7704">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">M Group <sup><xref ref-type="table-fn" rid="fn7704">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Age, y</bold>
</td><td rowspan="1" colspan="1">39.1 &#x000b1; 7.2</td><td rowspan="1" colspan="1">38.3 &#x000b1; 7.5</td><td rowspan="1" colspan="1">&#x0003e; 0.05</td></tr><tr><td rowspan="1" colspan="1">
<bold>Weight, kg</bold>
</td><td rowspan="1" colspan="1">68.8 &#x000b1; 12.5</td><td rowspan="1" colspan="1">69.6 &#x000b1; 11.1</td><td rowspan="1" colspan="1">&#x0003e; 0.05</td></tr><tr><td rowspan="1" colspan="1">
<bold>Operation time, min</bold>
</td><td rowspan="1" colspan="1">98 &#x000b1; 18</td><td rowspan="1" colspan="1">94 &#x000b1; 20</td><td rowspan="1" colspan="1">&#x0003e; 0.05</td></tr><tr><td rowspan="1" colspan="1">
<bold>Anesthesia time, min</bold>
</td><td rowspan="1" colspan="1">132 &#x000b1; 24</td><td rowspan="1" colspan="1">126 &#x000b1; 26</td><td rowspan="1" colspan="1">&#x0003e; 0.05</td></tr></tbody></table><table-wrap-foot><fn id="fn7704"><p><sup>a</sup> KM group; 1mg/mL ketamine and 0.5 mg/mL morphine solution; M group; 0.5mg/mL morphine plus normal saline solution.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl11609" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Postoperative Pain Scores in the Two Study Groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1"/><th style="text-align: left;" rowspan="1" colspan="1">KM Group <sup><xref ref-type="table-fn" rid="fn7705">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">M Group <sup><xref ref-type="table-fn" rid="fn7705">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>VAS Score 1 hour After Surgery</bold>
</td><td rowspan="1" colspan="1">2.4 &#x000b1; 1.1</td><td rowspan="1" colspan="1">3.6 &#x000b1; 1.3</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1">
<bold>VAS Score 6 hours After Surgery</bold>
</td><td rowspan="1" colspan="1">1.5 &#x000b1; 0.8</td><td rowspan="1" colspan="1">2.2 &#x000b1; 1.1</td><td rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="1" colspan="1">
<bold>VAS Score 24 hours After Surgery</bold>
</td><td rowspan="1" colspan="1">1 &#x000b1; 0.5</td><td rowspan="1" colspan="1">1.7 &#x000b1; 0.8</td><td rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="fn7705"><p><sup>a</sup> KM group; 1mg/mL ketamine and 0.5 mg/mL morphine solution; M group; 0.5mg/mL morphine plus normal saline solution.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl11611" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Postoperative Rescue Analgesia in the Two Study Groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th style="text-align: left;" rowspan="1" colspan="1">KM Group <sup><xref ref-type="table-fn" rid="fn7707">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">M Group <sup><xref ref-type="table-fn" rid="fn7707">a</xref></sup>, Mean &#x000b1; SD, (n = 70)</th><th style="text-align: left;" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Morphine, mg (Total 24 Hourdose)</bold>
</td><td rowspan="1" colspan="1">12 &#x000b1; 3</td><td rowspan="1" colspan="1">7 &#x000b1; 2</td><td rowspan="1" colspan="1">0.01</td></tr></tbody></table><table-wrap-foot><fn id="fn7707"><p><sup>a</sup> KM group; 1mg/mL ketamine and 0.5 mg/mL morphine solution; M group; 0.5mg/mL morphine plus normal saline solution.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl11610" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Postoperative Unwanted Side Effects in the Two Study Groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th style="vertical-align: top; text-align: left" rowspan="1" colspan="1">KM Group <sup><xref ref-type="table-fn" rid="fn7706">a</xref></sup>, Frequency (%), (n = 70)</th><th style="vertical-align: top; text-align: left" rowspan="1" colspan="1">M Group <sup><xref ref-type="table-fn" rid="fn7706">a</xref></sup>, Frequency (%), (n = 70)</th><th style="vertical-align: top; text-align: left" rowspan="1" colspan="1">P value for Chi Square</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Nausea</bold>
</td><td rowspan="1" colspan="1">10 (14)</td><td rowspan="1" colspan="1">4 (6)</td><td rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="1" colspan="1">
<bold>Vomiting</bold>
</td><td rowspan="1" colspan="1">6 (8.5)</td><td rowspan="1" colspan="1">1 (1.5)</td><td rowspan="1" colspan="1">0.02</td></tr><tr><td rowspan="1" colspan="1">
<bold>Patients requiring an antiemetic</bold>
</td><td rowspan="1" colspan="1">8 (11.5)</td><td rowspan="1" colspan="1">3 (4)</td><td rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="fn7706"><p><sup>a</sup> KM group; 1mg/mL ketamine and 0.5 mg/mL morphine solution; M group; 0.5mg/mL morphine plus normal saline solution.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec44006"><title>5. Discussion</title><p>The results of this study demonstrated improved analgesic effects of intravenous patient controlled analgesia with ketamine on postoperative pain in opium abusers. The effects of chronic opium abuse in altering the threshold of pain tolerance have previously been studied in a number of studies since the issue became a high priority in acute pain research (<xref rid="A14129R2" ref-type="bibr">2</xref>, <xref rid="A14129R4" ref-type="bibr">4</xref>, <xref rid="A14129R6" ref-type="bibr">6</xref>, <xref rid="A14129R7" ref-type="bibr">7</xref>, <xref rid="A14129R28" ref-type="bibr">28</xref>-<xref rid="A14129R32" ref-type="bibr">32</xref>). On the other hand, among this large list, there are not many studies that have assessed the effects of ketamine in postoperative pain suppression in these patients (<xref rid="A14129R17" ref-type="bibr">17</xref>, <xref rid="A14129R33" ref-type="bibr">33</xref>). </p><p>There is no doubt that acute pain treatment in such patients is a real challenge (<xref rid="A14129R33" ref-type="bibr">33</xref>, <xref rid="A14129R34" ref-type="bibr">34</xref>) and the usual pain killers (including; opioid agents, NSAIDs or even regional analgesic techniques) have less analgesic effects on them compared to the general population (<xref rid="A14129R5" ref-type="bibr">5</xref>-<xref rid="A14129R7" ref-type="bibr">7</xref>, <xref rid="A14129R32" ref-type="bibr">32</xref>, <xref rid="A14129R33" ref-type="bibr">33</xref>, <xref rid="A14129R35" ref-type="bibr">35</xref>). Previous studies have demonstrated other clinical problems in opium abusing patients, especially when they are managed for their acute pain status (<xref rid="A14129R2" ref-type="bibr">2</xref>, <xref rid="A14129R4" ref-type="bibr">4</xref>, <xref rid="A14129R7" ref-type="bibr">7</xref>, <xref rid="A14129R32" ref-type="bibr">32</xref>, <xref rid="A14129R33" ref-type="bibr">33</xref>, <xref rid="A14129R36" ref-type="bibr">36</xref>). Ketamine, an NMDA antagonist, acts through its specific receptors which are not frequently exposed to drugs abused by these patients before their surgery (<xref rid="A14129R17" ref-type="bibr">17</xref>, <xref rid="A14129R34" ref-type="bibr">34</xref>, <xref rid="A14129R37" ref-type="bibr">37</xref>-<xref rid="A14129R39" ref-type="bibr">39</xref>). This is possibly one of the main explanations justifying our findings regarding the acceptable effects of ketamine in opium abusers. Results of the present study also demonstrated the opium sparing effects of ketamine used as an adjuvant analgesic to opioids; while its side effects are acceptable. The adjuvant use of ketamine could be an interesting topic for clinicians managing acute pain in these patients.</p><p>During recent years, there have been a number of studies stating their concerns regarding the possible unwanted effects of ketamine (<xref rid="A14129R40" ref-type="bibr">40</xref>-<xref rid="A14129R46" ref-type="bibr">46</xref>). These are usually related to the untoward effects of ketamine on neuro-developmental issues in pediatric patients and not in the adult population. Nonetheless, there are some alerts regarding possible apoptotic effects of ketamine on liver cells, especially in patients exposed to the drug frequently or as an abuse form (<xref rid="A14129R41" ref-type="bibr">41</xref>, <xref rid="A14129R47" ref-type="bibr">47</xref>-<xref rid="A14129R49" ref-type="bibr">49</xref>). In these studies, the authors are usually 'apprehensive' of the effects of ketamine on infants and children.</p><p>There are a number of limitations in our study; first of all, our patients did not include females and some unwanted effects of ketamine are more commonly seen in women (including the emergence reaction). In addition, our patients were only in the orthopedic ward, while other types of procedures that produce postoperative pain (like the GI tract, respiratory tract, or Central Nervous System surgeries) were not involved, and therefore the side effects of ketamine could be more severe in such cases. Overall, our study demonstrated the effectiveness of ketamine's analgesic effects when used as an adjuvant analgesic accompanied with morphine, and as a PCA analgesia in opium abuser patients undergoing orthopedic surgery.</p></sec></body><back><ack><p>The authors would like to acknowledge the generous help of the Taleghani Hospital OR, ward nurses and physicians, and also, the personnel of the Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</p></ack><fn-group><fn id="afn24458" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold>In opium abusers, the management of acute postoperative pain is a challenging task; mainly due to chronic exposure of the patients with the analgesic drugs; however, this study demonstrated that using intravenous patient controlled analgesia with ketamine could improve the analgesic effects of our medications regarding acute postoperative pain.</p></fn><fn id="afn24459" fn-type="other"><p><bold>Authors&#x02019; Contribution:</bold>Mastane Dahi-Taleghani, Benjamin Fazli, Mahshid Ghasemi and Maryam Vosoughian designed the study, collected the clinical data and prepared the manuscript. Ali Dabbagh had a role in the design, data analysis, writing and preparation of the manuscript.</p></fn><fn id="afn24460" fn-type="financial-disclosure"><p><bold>Financial Disclosure:</bold>None of the authors have any financial disclosure.</p></fn><fn id="afn24461" fn-type="supported-by"><p><bold>Funding/Support:</bold>This study was supported financially in part by a research grant from the Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</p></fn></fn-group><ref-list><title>References</title><ref id="A14129R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>American Society of Anesthesiologists Task Force on Acute Pain</surname><given-names>M</given-names></name></person-group><article-title>Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.</article-title><source>Anesthesiology.</source><year>2012</year><volume>116</volume><issue>2</issue><fpage>248</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31823c1030</pub-id><pub-id pub-id-type="pmid">22227789</pub-id></element-citation></ref><ref id="A14129R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azarasa</surname><given-names>M</given-names></name><name><surname>Azarfarin</surname><given-names>R</given-names></name><name><surname>Changizi</surname><given-names>A</given-names></name><name><surname>Alizadehasl</surname><given-names>A</given-names></name></person-group><article-title>Substance use among Iranian cardiac surgery patients and its effects on short-term outcome.</article-title><source>Anesth Analg.</source><year>2009</year><volume>109</volume><issue>5</issue><fpage>1553</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e3181b76371</pub-id><pub-id pub-id-type="pmid">19843794</pub-id></element-citation></ref><ref id="A14129R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>C</given-names></name><name><surname>McConaghy</surname><given-names>P</given-names></name></person-group><article-title>Perioperative management of patients taking treatment for chronic pain.</article-title><source>BMJ.</source><year>2012</year><volume>345</volume><elocation-id>e14129</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.e4148</pub-id><pub-id pub-id-type="pmid">22761087</pub-id></element-citation></ref><ref id="A14129R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khademi</surname><given-names>H</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Jafari</surname><given-names>E</given-names></name><name><surname>Salahi</surname><given-names>R</given-names></name><name><surname>Semnani</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.</article-title><source>BMJ.</source><year>2012</year><volume>344</volume><elocation-id>e14129</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.e2502</pub-id><pub-id pub-id-type="pmid">22511302</pub-id></element-citation></ref><ref id="A14129R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safari</surname><given-names>F</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Sharifnia</surname><given-names>M</given-names></name></person-group><article-title>The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers.</article-title><source>Korean J Anesthesiol.</source><year>2012</year><volume>63</volume><issue>6</issue><fpage>521</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.4097/kjae.2012.63.6.521</pub-id><pub-id pub-id-type="pmid">23277813</pub-id></element-citation></ref><ref id="A14129R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Dahi-Taleghani</surname><given-names>M</given-names></name><name><surname>Elyasi</surname><given-names>H</given-names></name><name><surname>Vosoughian</surname><given-names>M</given-names></name><name><surname>Malek</surname><given-names>B</given-names></name><name><surname>Rajaei</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Duration of spinal anesthesia with bupivacaine in chronic opium abusers undergoing lower extremity orthopedic surgery.</article-title><source>Arch Iran Med.</source><year>2007</year><volume>10</volume><issue>3</issue><fpage>316</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17604467</pub-id></element-citation></ref><ref id="A14129R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vosoughian</surname><given-names>M</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Rajaei</surname><given-names>S</given-names></name><name><surname>Maftuh</surname><given-names>H</given-names></name></person-group><article-title>The duration of spinal anesthesia with 5% lidocaine in chronic opium abusers compared with nonabusers.</article-title><source>Anesth Analg.</source><year>2007</year><volume>105</volume><issue>2</issue><fpage>531</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1213/01.ane.0000268496.46141.4f</pub-id><pub-id pub-id-type="pmid">17646519</pub-id></element-citation></ref><ref id="A14129R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>RF</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name></person-group><article-title>Perioperative ketamine for acute postoperative pain.</article-title><source>Cochrane Database Syst Rev.</source><year>2006</year><issue>1</issue><fpage>CD004603</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD004603.pub2</pub-id><pub-id pub-id-type="pmid">16437490</pub-id></element-citation></ref><ref id="A14129R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>EN</given-names></name><name><surname>Lydic</surname><given-names>R</given-names></name><name><surname>Schiff</surname><given-names>ND</given-names></name></person-group><article-title>General anesthesia, sleep, and coma.</article-title><source>N Engl J Med.</source><year>2010</year><volume>363</volume><issue>27</issue><fpage>2638</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1056/NEJMra0808281</pub-id><pub-id pub-id-type="pmid">21190458</pub-id></element-citation></ref><ref id="A14129R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canet</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>J</given-names></name></person-group><article-title>Ketamine: a familiar drug we trust.</article-title><source>Anesthesiology.</source><year>2012</year><volume>116</volume><issue>1</issue><fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31823da398</pub-id><pub-id pub-id-type="pmid">22080003</pub-id></element-citation></ref><ref id="A14129R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chazan</surname><given-names>S</given-names></name><name><surname>Ekstein</surname><given-names>MP</given-names></name><name><surname>Marouani</surname><given-names>N</given-names></name><name><surname>Weinbroum</surname><given-names>AA</given-names></name></person-group><article-title>Ketamine for acute and subacute pain in opioid-tolerant patients.</article-title><source>J Opioid Manag.</source><year>2008</year><volume>4</volume><issue>3</issue><fpage>173</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18717513</pub-id></element-citation></ref><ref id="A14129R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galinski</surname><given-names>M</given-names></name><name><surname>Dolveck</surname><given-names>F</given-names></name><name><surname>Combes</surname><given-names>X</given-names></name><name><surname>Limoges</surname><given-names>V</given-names></name><name><surname>Smail</surname><given-names>N</given-names></name><name><surname>Pommier</surname><given-names>V</given-names></name><etal>et al.</etal></person-group><article-title>Management of severe acute pain in emergency settings: ketamine reduces morphine consumption.</article-title><source>Am J Emerg Med.</source><year>2007</year><volume>25</volume><issue>4</issue><fpage>385</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2006.11.016</pub-id><pub-id pub-id-type="pmid">17499654</pub-id></element-citation></ref><ref id="A14129R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharaei</surname><given-names>B</given-names></name><name><surname>Jafari</surname><given-names>A</given-names></name><name><surname>Aghamohammadi</surname><given-names>H</given-names></name><name><surname>Kamranmanesh</surname><given-names>M</given-names></name><name><surname>Poorzamani</surname><given-names>M</given-names></name><name><surname>Elyassi</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Opioid-sparing effect of preemptive bolus low-dose ketamine for moderate sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: a randomized clinical trial.</article-title><source>Anesth Analg.</source><year>2013</year><volume>116</volume><issue>1</issue><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e31826f0622</pub-id><pub-id pub-id-type="pmid">23223117</pub-id></element-citation></ref><ref id="A14129R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>K</given-names></name><name><surname>Stirling</surname><given-names>A</given-names></name><name><surname>McKay</surname><given-names>WP</given-names></name><name><surname>Lim</surname><given-names>HJ</given-names></name></person-group><article-title>A systematic review of intravenous ketamine for postoperative analgesia.</article-title><source>Can J Anaesth.</source><year>2011</year><volume>58</volume><issue>10</issue><fpage>911</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s12630-011-9560-0</pub-id><pub-id pub-id-type="pmid">21773855</pub-id></element-citation></ref><ref id="A14129R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loftus</surname><given-names>RW</given-names></name><name><surname>Yeager</surname><given-names>MP</given-names></name><name><surname>Clark</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Abdu</surname><given-names>WA</given-names></name><name><surname>Sengupta</surname><given-names>DK</given-names></name><etal>et al.</etal></person-group><article-title>Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery.</article-title><source>Anesthesiology.</source><year>2010</year><volume>113</volume><issue>3</issue><fpage>639</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181e90914</pub-id><pub-id pub-id-type="pmid">20693876</pub-id></element-citation></ref><ref id="A14129R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadivelu</surname><given-names>N</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Narayan</surname><given-names>D</given-names></name></person-group><article-title>Recent advances in postoperative pain management.</article-title><source>Yale J Biol Med.</source><year>2010</year><volume>83</volume><issue>1</issue><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">20351978</pub-id></element-citation></ref><ref id="A14129R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vosoughin</surname><given-names>M</given-names></name><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name></person-group><article-title>Intravenous ketamine compared with diclofenac suppository in suppressing acute postoperative pain in women undergoing gynecologic laparoscopy.</article-title><source>J Anesth.</source><year>2012</year><volume>26</volume><issue>5</issue><fpage>732</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00540-012-1399-1</pub-id><pub-id pub-id-type="pmid">22576074</pub-id></element-citation></ref><ref id="A14129R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeom</surname><given-names>JH</given-names></name><name><surname>Chon</surname><given-names>MS</given-names></name><name><surname>Jeon</surname><given-names>WJ</given-names></name><name><surname>Shim</surname><given-names>JH</given-names></name></person-group><article-title>Peri-operative ketamine with the ambulatory elastometric infusion pump as an adjuvant to manage acute postoperative pain after spinal fusion in adults: a prospective randomized trial.</article-title><source>Korean J Anesthesiol.</source><year>2012</year><volume>63</volume><issue>1</issue><fpage>54</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.4097/kjae.2012.63.1.54</pub-id><pub-id pub-id-type="pmid">22870366</pub-id></element-citation></ref><ref id="A14129R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>N</given-names></name><name><surname>Tramer</surname><given-names>MR</given-names></name></person-group><article-title>Ketamine and postoperative pain--a quantitative systematic review of randomised trials.</article-title><source>Pain.</source><year>2005</year><volume>113</volume><issue>1-2</issue><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2004.09.036</pub-id><pub-id pub-id-type="pmid">15621365</pub-id></element-citation></ref><ref id="A14129R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joly</surname><given-names>V</given-names></name><name><surname>Richebe</surname><given-names>P</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Fletcher</surname><given-names>D</given-names></name><name><surname>Maurette</surname><given-names>P</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><etal>et al.</etal></person-group><article-title>Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine.</article-title><source>Anesthesiology.</source><year>2005</year><volume>103</volume><issue>1</issue><fpage>147</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">15983467</pub-id></element-citation></ref><ref id="A14129R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>B</given-names></name><name><surname>Subramaniam</surname><given-names>K</given-names></name><name><surname>Pawar</surname><given-names>DK</given-names></name><name><surname>Sennaraj</surname><given-names>B</given-names></name></person-group><article-title>Preoperative epidural ketamine in combination with morphine does not have a clinically relevant intra- and postoperative opioid-sparing effect.</article-title><source>Anesth Analg.</source><year>2001</year><volume>93</volume><issue>5</issue><fpage>1321</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11682423</pub-id></element-citation></ref><ref id="A14129R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>M</given-names></name></person-group><article-title>Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.</article-title><source>Curr Opin Anaesthesiol.</source><year>2009</year><volume>22</volume><issue>5</issue><fpage>618</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1097/ACO.0b013e32832e7af6</pub-id><pub-id pub-id-type="pmid">19535974</pub-id></element-citation></ref><ref id="A14129R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudcova</surname><given-names>J</given-names></name><name><surname>McNicol</surname><given-names>E</given-names></name><name><surname>Quah</surname><given-names>C</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>Carr</surname><given-names>DB</given-names></name></person-group><article-title>Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.</article-title><source>Cochrane Database Syst Rev.</source><year>2006</year><issue>4</issue><fpage>CD003348</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD003348.pub2</pub-id><pub-id pub-id-type="pmid">17054167</pub-id></element-citation></ref><ref id="A14129R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friede</surname><given-names>T</given-names></name><name><surname>Kieser</surname><given-names>M</given-names></name></person-group><article-title>Sample size recalculation in internal pilot study designs: a review.</article-title><source>Biom J.</source><year>2006</year><volume>48</volume><issue>4</issue><fpage>537</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">16972704</pub-id></element-citation></ref><ref id="A14129R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>J</given-names></name><name><surname>Engebretsen</surname><given-names>L</given-names></name><name><surname>Dainty</surname><given-names>K</given-names></name><name><surname>Isakos Scientific Committee.</surname></name></person-group><article-title>Considerations on sample size and power calculations in randomized clinical trials.</article-title><source>Arthroscopy.</source><year>2003</year><volume>19</volume><issue>9</issue><fpage>997</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14608320</pub-id></element-citation></ref><ref id="A14129R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandis</surname><given-names>N</given-names></name><name><surname>Polychronopoulou</surname><given-names>A</given-names></name><name><surname>Eliades</surname><given-names>T</given-names></name></person-group><article-title>Sample size estimation: an overview with applications to orthodontic clinical trial designs.</article-title><source>Am J Orthod Dentofacial Orthop.</source><year>2011</year><volume>140</volume><issue>4</issue><fpage>e141</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.ajodo.2011.04.021</pub-id><pub-id pub-id-type="pmid">21967951</pub-id></element-citation></ref><ref id="A14129R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Timmesfeld</surname><given-names>N</given-names></name><name><surname>Muller</surname><given-names>HH</given-names></name></person-group><article-title>An overview of statistical approaches for adaptive designs and design modifications.</article-title><source>Biom J.</source><year>2006</year><volume>48</volume><issue>4</issue><fpage>507</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16972702</pub-id></element-citation></ref><ref id="A14129R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asiabanha</surname><given-names>M</given-names></name><name><surname>Asadikaram</surname><given-names>G</given-names></name><name><surname>Rahnema</surname><given-names>A</given-names></name><name><surname>Mahmoodi</surname><given-names>M</given-names></name><name><surname>Hasanshahi</surname><given-names>G</given-names></name><name><surname>Hashemi</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Chronic Opium Treatment Can Differentially Induce Brain and Liver Cells Apoptosis in Diabetic and Non-diabetic Male and Female Rats.</article-title><source>Korean J Physiol Pharmacol.</source><year>2011</year><volume>15</volume><issue>6</issue><fpage>327</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4196/kjpp.2011.15.6.327</pub-id><pub-id pub-id-type="pmid">22359469</pub-id></element-citation></ref><ref id="A14129R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besharat</surname><given-names>S</given-names></name><name><surname>Jabbari</surname><given-names>A</given-names></name><name><surname>Besharat</surname><given-names>M</given-names></name></person-group><article-title>Opium as a fatal substance.</article-title><source>Indian J Pediatr.</source><year>2008</year><volume>75</volume><issue>11</issue><fpage>1125</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s12098-008-0166-7</pub-id><pub-id pub-id-type="pmid">18810361</pub-id></element-citation></ref><ref id="A14129R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Moghadam</surname><given-names>SF</given-names></name><name><surname>Rajaei</surname><given-names>S</given-names></name><name><surname>Mansouri</surname><given-names>Z</given-names></name><name><surname>Manaheji</surname><given-names>HS</given-names></name></person-group><article-title>Can repeated exposure to morphine change the spinal analgesic effects of lidocaine in rats?</article-title><source>J Res Med Sci.</source><year>2011</year><volume>16</volume><issue>10</issue><fpage>1361</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22973332</pub-id></element-citation></ref><ref id="A14129R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Saadatian-Elahi</surname><given-names>M</given-names></name><name><surname>Nouraie</surname><given-names>M</given-names></name><name><surname>Malekshah</surname><given-names>AF</given-names></name><name><surname>Rakhshani</surname><given-names>N</given-names></name><name><surname>Salahi</surname><given-names>R</given-names></name><etal>et al.</etal></person-group><article-title>Golestan cohort study of oesophageal cancer: feasibility and first results.</article-title><source>Br J Cancer.</source><year>2005</year><volume>92</volume><issue>1</issue><fpage>176</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6602249</pub-id><pub-id pub-id-type="pmid">15597107</pub-id></element-citation></ref><ref id="A14129R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saadat</surname><given-names>H</given-names></name><name><surname>Ziai</surname><given-names>SA</given-names></name><name><surname>Ghanemnia</surname><given-names>M</given-names></name><name><surname>Namazi</surname><given-names>MH</given-names></name><name><surname>Safi</surname><given-names>M</given-names></name><name><surname>Vakili</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients.</article-title><source>PLoS One.</source><year>2012</year><volume>7</volume><issue>9</issue><elocation-id>e14129</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044939</pub-id><pub-id pub-id-type="pmid">23028694</pub-id></element-citation></ref><ref id="A14129R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabbary Moghaddam</surname><given-names>M</given-names></name><name><surname>Ommi</surname><given-names>D</given-names></name><name><surname>Mirkheshti</surname><given-names>A</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Memary</surname><given-names>E</given-names></name><name><surname>Sadeghi</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Effects of clonidine premedication upon postoperative shivering and recovery time in patients with and without opium addiction after elective leg fracture surgeries.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>2</volume><issue>3</issue><fpage>107</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.5812/aapm.7143</pub-id><pub-id pub-id-type="pmid">24244918</pub-id></element-citation></ref><ref id="A14129R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javid</surname><given-names>MJ</given-names></name><name><surname>Hajijafari</surname><given-names>M</given-names></name><name><surname>Hajipour</surname><given-names>A</given-names></name><name><surname>Makarem</surname><given-names>J</given-names></name><name><surname>Khazaeipour</surname><given-names>Z</given-names></name></person-group><article-title>Evaluation of a low dose ketamine in post tonsillectomy pain relief: a randomized trial comparing intravenous and subcutaneous ketamine in pediatrics.</article-title><source>Anesth Pain Med.</source><year>2012</year><volume>2</volume><issue>2</issue><fpage>85</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5812/aapm.4399</pub-id><pub-id pub-id-type="pmid">24223344</pub-id></element-citation></ref><ref id="A14129R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbagh</surname><given-names>A</given-names></name></person-group><article-title>Clonidine: An old friend newly rediscovered.</article-title><source>Anesth Pain Med.</source><year>2011</year><volume>1</volume><issue>1</issue><fpage>8</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5812/kowsar.22287523.1802</pub-id></element-citation></ref><ref id="A14129R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najafi</surname><given-names>M</given-names></name><name><surname>Sheikhvatan</surname><given-names>M</given-names></name></person-group><article-title>Does analgesic effect of opium hamper the adverse effects of severe coronary artery disease on quality of life in addicted patients?</article-title><source>Anesth Pain Med.</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>22</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.5812/aapm.5139</pub-id><pub-id pub-id-type="pmid">24223329</pub-id></element-citation></ref><ref id="A14129R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behdad</surname><given-names>S</given-names></name><name><surname>Hajiesmaeili</surname><given-names>MR</given-names></name><name><surname>Abbasi</surname><given-names>HR</given-names></name><name><surname>Ayatollahi</surname><given-names>V</given-names></name><name><surname>Khadiv</surname><given-names>Z</given-names></name><name><surname>Sedaghat</surname><given-names>A</given-names></name></person-group><article-title>Analgesic Effects of Intravenous Ketamine during Spinal Anesthesia in Pregnant Women Undergone Caesarean Section; A Randomized Clinical Trial.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>2</issue><fpage>230</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.5812/aapm.7034</pub-id><pub-id pub-id-type="pmid">24282773</pub-id></element-citation></ref><ref id="A14129R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini Jahromi</surname><given-names>SA</given-names></name><name><surname>Hosseini Valami</surname><given-names>SM</given-names></name><name><surname>Hatamian</surname><given-names>S</given-names></name></person-group><article-title>Comparison between effect of lidocaine, morphine and ketamine spray on post-tonsillectomy pain in children.</article-title><source>Anesth Pain Med.</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.5812/aapm.4092</pub-id><pub-id pub-id-type="pmid">24223328</pub-id></element-citation></ref><ref id="A14129R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajavi</surname><given-names>M</given-names></name><name><surname>Emami</surname><given-names>A</given-names></name><name><surname>Etezadi</surname><given-names>F</given-names></name><name><surname>Safari</surname><given-names>S</given-names></name><name><surname>Sharifi</surname><given-names>A</given-names></name><name><surname>Shariat Moharari</surname><given-names>R</given-names></name></person-group><article-title>Conscious Sedation and Analgesia in Colonoscopy: Ketamine/Propofol Combination has Superior Patient Satisfaction Versus Fentanyl/Propofol.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>208</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.5812/aapm.9653</pub-id><pub-id pub-id-type="pmid">24223364</pub-id></element-citation></ref><ref id="A14129R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosnjak</surname><given-names>ZJ</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Canfield</surname><given-names>S</given-names></name><name><surname>Muravyeva</surname><given-names>MY</given-names></name><name><surname>Kikuchi</surname><given-names>C</given-names></name><name><surname>Wells</surname><given-names>CW</given-names></name><etal>et al.</etal></person-group><article-title>Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway.</article-title><source>Curr Drug Saf.</source><year>2012</year><volume>7</volume><issue>2</issue><fpage>106</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">22873495</pub-id></element-citation></ref><ref id="A14129R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brambrink</surname><given-names>AM</given-names></name><name><surname>Evers</surname><given-names>AS</given-names></name><name><surname>Avidan</surname><given-names>MS</given-names></name><name><surname>Farber</surname><given-names>NB</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Martin</surname><given-names>LD</given-names></name><etal>et al.</etal></person-group><article-title>Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain.</article-title><source>Anesthesiology.</source><year>2012</year><volume>116</volume><issue>2</issue><fpage>372</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e318242b2cd</pub-id><pub-id pub-id-type="pmid">22222480</pub-id></element-citation></ref><ref id="A14129R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>S</given-names></name><name><surname>Gaza</surname><given-names>N</given-names></name><name><surname>Werdehausen</surname><given-names>R</given-names></name><name><surname>Hermanns</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>I</given-names></name><name><surname>Durieux</surname><given-names>ME</given-names></name><etal>et al.</etal></person-group><article-title>Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells.</article-title><source>Br J Anaesth.</source><year>2010</year><volume>105</volume><issue>3</issue><fpage>347</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1093/bja/aeq169</pub-id><pub-id pub-id-type="pmid">20659914</pub-id></element-citation></ref><ref id="A14129R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhard</surname><given-names>K</given-names></name><name><surname>Werner</surname><given-names>C</given-names></name><name><surname>Eberspacher</surname><given-names>E</given-names></name><name><surname>Bachl</surname><given-names>M</given-names></name><name><surname>Blobner</surname><given-names>M</given-names></name><name><surname>Hildt</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats.</article-title><source>Anesth Analg.</source><year>2003</year><volume>96</volume><issue>2</issue><lpage>31</lpage><fpage>524</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12538207</pub-id></element-citation></ref><ref id="A14129R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponten</surname><given-names>E</given-names></name><name><surname>Viberg</surname><given-names>H</given-names></name><name><surname>Gordh</surname><given-names>T</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Fredriksson</surname><given-names>A</given-names></name></person-group><article-title>Clonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice.</article-title><source>Acta Anaesthesiol Scand.</source><year>2012</year><volume>56</volume><issue>8</issue><fpage>1058</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2012.02722.x</pub-id><pub-id pub-id-type="pmid">22694670</pub-id></element-citation></ref><ref id="A14129R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagmurdur</surname><given-names>H</given-names></name><name><surname>Aksoy</surname><given-names>M</given-names></name><name><surname>Arslan</surname><given-names>M</given-names></name><name><surname>Baltaci</surname><given-names>B</given-names></name></person-group><article-title>The effects of propofol and ketamine on gut mucosal epithelial apoptosis in rats after burn injury.</article-title><source>Eur J Anaesthesiol.</source><year>2007</year><volume>24</volume><issue>1</issue><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1017/S0265021506000986</pub-id><pub-id pub-id-type="pmid">16824247</pub-id></element-citation></ref><ref id="A14129R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Paule</surname><given-names>MG</given-names></name><name><surname>Newport</surname><given-names>GD</given-names></name><name><surname>Sadovova</surname><given-names>N</given-names></name><name><surname>Berridge</surname><given-names>MS</given-names></name><name><surname>Apana</surname><given-names>SM</given-names></name><etal>et al.</etal></person-group><article-title>MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH.</article-title><source>J Neural Transm.</source><year>2011</year><volume>118</volume><issue>2</issue><fpage>203</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00702-010-0499-z</pub-id><pub-id pub-id-type="pmid">20963452</pub-id></element-citation></ref><ref id="A14129R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Canfield</surname><given-names>S</given-names></name><name><surname>Muravyeva</surname><given-names>MY</given-names></name><name><surname>Kikuchi</surname><given-names>C</given-names></name><name><surname>Zaja</surname><given-names>I</given-names></name><etal>et al.</etal></person-group><article-title>Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway.</article-title><source>Anesth Analg.</source><year>2013</year><volume>116</volume><issue>4</issue><fpage>869</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e3182860fc9</pub-id><pub-id pub-id-type="pmid">23460563</pub-id></element-citation></ref><ref id="A14129R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Baek</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>XH</given-names></name><name><surname>Athiraman</surname><given-names>U</given-names></name><etal>et al.</etal></person-group><article-title>Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain.</article-title><source>Anesthesiology.</source><year>2012</year><volume>117</volume><issue>1</issue><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31825ae693</pub-id><pub-id pub-id-type="pmid">22617253</pub-id></element-citation></ref><ref id="A14129R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>J</given-names></name></person-group><article-title>Wherefore ketamine?</article-title><source>Curr Opin Anaesthesiol.</source><year>2010</year><volume>23</volume><issue>4</issue><fpage>455</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1097/ACO.0b013e32833b49b3</pub-id><pub-id pub-id-type="pmid">20531172</pub-id></element-citation></ref></ref-list></back></article>